| Size & multiples | |||
| Market Cap | $6.51B | Enterprise Value | $6.58B |
| P/E (TTM) | 29.33× | PEG (trailing) | 0.28× |
| P/S | 4.21× | P/FCF | 17.97× |
| EV/EBITDA | 17.83× | EV/EBIT | 22.69× |
| EV/Sales | 4.26× | EV/FCF | 18.17× |
| FCF Yield | 5.57% | Buyback Yield | 4.61% |
| Owner Earnings (TTM) | $312.8M | Owner Earnings Yield | 4.81% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 0.01 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 4.05% |
| After-tax Cost of Debt | 2.58% | Synthetic credit rating | AAA |
| Cost of Debt · embedded (pre-tax) | 3.47% | Cost of Debt · marginal (synthetic) | 4.40% |
| WACC | 3.94% | ROIC | 22.66% |
| EVA Spread (ROIC−WACC) | 18.73% | EVA | $243.5M |
Synthetic rating = ICR-based credit-quality read (Damodaran), not an agency rating.
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM $3.41 · revenue TTM $1.55B · FCF TTM $362.4M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Rich vs Health Care on P/E, EV/EBITDA
P/E 60th · EV/EBITDA 59th percentile in the Health Care pool — placement read per multiple; the API emits no single blended figure, so none is shown.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| P/E | 29.3x | 24.4x | 12.9x–38.8x | 60 ↑rich |
| EV/EBITDA | 17.6x | 15.2x | 9.9x–24.7x | 59 ↑rich |
| FCF Yield | 5.3% | -7.9% | -35.6%–1.4% | 88 ↑strong |
| Net Margin | 15.2% | -21.2% | -325.3%–7.2% | 86 ↑strong |
| Operating Margin | 20.2% | -34.5% | -552.0%–8.0% | 90 ↑strong |
| ROE | 21.4% | -36.8% | -92.5%–4.5% | 91 ↑strong |
